AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results
Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026
RANCHO CUCAMONGA, Calif. , Aug. 6, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) ("Amphastar" or the "Company"), a biopharmaceutical company focused on developing, manufacturing,...
Barchart Research What to Expect from AMPH Earnings AMPH Generated August 5, 2026 Current Price $20.24 EPS Estimate $$0.51 Consensus Rating Hold Average Move 11.64% Amphastar's Earnings Call Will Reveal...
What To Expect From Amphastar Pharmaceuticals’s (AMPH) Q2 Earnings
1 Value Stock to Own for Decades and 2 Facing Challenges
RANCHO CUCAMONGA, Calif. , July 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its second quarter of 2026 ended...
1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds
3 Reasons AMPH is Risky and 1 Stock to Buy Instead